GOSS (Gossamer Bio) Total Liabilities: $290.38 Mil (As of Mar. 2026)


GOSS Gossamer Bio Inc GOSS
16 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Gossamer Bio Total Liabilities?

Gossamer Bio GOSS -2.65% 16 Total Liabilities is $290.38 Mil as of Mar. 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review.

Gossamer Bio's Total Liabilities for the quarter that ended in Mar. 2026 was $290.38 Mil.

Gossamer Bio's quarterly Total Liabilities increased from Sep. 2025 ($291.15 Mil) to Dec. 2025 ($295.01 Mil) but then declined from Dec. 2025 ($295.01 Mil) to Mar. 2026 ($290.38 Mil).

Gossamer Bio's annual Total Liabilities increased from Dec. 2023 ($249.15 Mil) to Dec. 2024 ($285.80 Mil) and increased from Dec. 2024 ($285.80 Mil) to Dec. 2025 ($295.01 Mil).

Gossamer Bio Total Liabilities Historical Data

* Premium members only.

The historical data trend for Gossamer Bio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gossamer Bio Total Liabilities Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 222.19 260.37 249.15 285.80 295.01

Gossamer Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 286.84 287.03 291.15 295.01 290.38
GOSS
16GF Score
Gossamer Bio Inc GOSS
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gossamer Bio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Gossamer Bio's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=63.435+(201.968+2.1316282072803E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+29.606+0+0)
=295.01

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=172.249--122.76
=295.01

Gossamer Bio's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=56.506+(201.976+7.105427357601E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+31.9+0+0)
=290.38

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=128.899--161.483
=290.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $290.38 Mil mean?
Gossamer Bio (GOSS) has a Total Liabilities of $290.38 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Gossamer Bio and its competitors.
Is Gossamer Bio's Total Liabilities too high?
Gossamer Bio's current Total Liabilities is $290.38 Mil. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's Total Liabilities compare to TIL and ATYR?
Gossamer Bio's Total Liabilities of $290.38 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Gossamer Bio and its competitors. Gossamer Bio's current Total Liabilities is $290.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current Total Liabilities of $290.38 Mil. The current Total Liabilities is $290.38 Mil. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current Total Liabilities is $290.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score

Get the complete analysis for GOSS

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price